follows : 1. Income from medical treatments in the consolidated financial Statement went up 6.42% due to income from Chiang Mai Ram Medical Business Plc.”CMR”, a subsidiary amount Baht 3,935.33 million went
December 2021 which was audited by the auditor. The Company’s overall performance can be summarized as follows: Performance Unit: THB Million 2020 2021 Inc./(Dec.) % Inc./(Dec.) Services income 345.53 515.00
ended 31 March 2023 which was reviewed by the auditor. The Company’s overall performance can be summarized as follows: Performance Unit: THB Million 1Q2022 1Q2023 Inc. (Dec.) % Inc. (Dec.) Services income
million or 66.26%. According to the abovementioned, the net profit has changed by more than 20%, comparing to the same period of 2019 which is clarified as below Income : (Unit: Million Baht) Consolidated
of last year in the amount of Baht 3.99 million, due to income from earned premium net of reinsurance and commission and brokerage income in this quarter decrease from the same period of last year in
.(Dec.) % Inc.(Dec.) Services income 62.06 76.71 14.65 23.61% 126.87 155.72 28.85 22.74% Cost of rendering of services (49.49) (54.54) (5.05) 10.21% (100.51) (111.11) (10.59) 10.54% Gross profit 12.58
The Company had recorded net gain from write-off expired legal prescription of debts for year 2018 amounted to THB 119 million according to the resolve approval from the Company’s Board of Directors on
expired legal prescription of debts for year 2018 amounted to THB 119 million according to the resolve approval from the Company’s Board of Directors on 9th and 19th November 2018. 5. Performance of the
Company will further inform via the SET system. 2) Right adjustment as a result of dividend payment in the amount of money exceeding 80 percent of net profit after income tax subject by the Company The
past, which GJS defaulted from the contracts), which is as a measure to resolve and debt restructure from GJS, the interest rate of long-term loan at 12% p.a. (Separated financial costs: THB 207 million